group. Analysing burden estimates at this aggregated level is important from both the clinical and population-health perspectives, given that the organization of services in many LMICs does not separate neurological disorders from mental disorders, something seen as a progression of Western medical subspecialization. Specifically, in this paper, we quantify the global disease burden attributable to mental, neurological, and substance use disorders and explore variations in burden by disorder type, age, gender, year, and region.
